Lyell Immunopharma, Inc.
Shares Outstanding
| Period | Shares Outstanding |
|---|---|
| Dec 2020 | 155.7M |
| Mar 2021 | 172.7M |
| Jun 2021 | 427.1M |
| Aug 2021 | 2.39B |
| Sep 2021 | 2.39B |
| Nov 2021 | 2.40B |
| Dec 2021 | 242.7M |
| Mar 2022 | 245.4M |
| Mar 2022 | 244.2M |
| May 2022 | 246.1M |
| Jun 2022 | 246.3M |
| Aug 2022 | 247.8M |
| Sep 2022 | 248.3M |
| Nov 2022 | 249.3M |
| Dec 2022 | 249.6M |
| Feb 2023 | 249.6M |
| Mar 2023 | 249.6M |
| Apr 2023 | 249.6M |
| Jun 2023 | 250.2M |
| Aug 2023 | 251.0M |
| Sep 2023 | 251.3M |
| Nov 2023 | 251.9M |
| Dec 2023 | 254.0M |
| Feb 2024 | 254.1M |
| Mar 2024 | 254.3M |
| May 2024 | 254.9M |
| Jun 2024 | 12.8M |
| Aug 2024 | 256.0M |
| Sep 2024 | 12.8M |
| Nov 2024 | 279.2M |
| Dec 2024 | 14.7M |
| Mar 2025 | 295.2M |
| Mar 2025 | 14.8M |
| May 2025 | 295.3M |
| Jun 2025 | 14.8M |
| Aug 2025 | 19.2M |
| Sep 2025 | 18.3M |
| Nov 2025 | 21.2M |
| Dec 2025 | 21.3M |
| Mar 2026 | 23.3M |
| Mar 2026 | 21.9M |
| May 2026 | 23.3M |
| Jun 2026 | 23.4M |
| Aug 2026 | 24.5M |